We are live on ! Find out more
CCM

Crabel Capital Management Portfolio holdings

AUM $10.8M
1-Year Est. Return 3.34%
This Fund
S&P 500
This Quarter Est. Return
+8.09%
1 Year Est. Return
-3.34%
3 Year Est. Return
+22.66%
5 Year Est. Return
+189.97%
10 Year Est. Return
–
AUM
$242M
AUM Growth
+$16.9M
Cap. Flow
+$11.3M
Cap. Flow %
4.64%
Top 10 Hldgs %
35.08%
Holding
130
New
46
Increased
34
Reduced
25
Closed
20

Top Buys

Rank Stock Value
1
ARNC
Arconic Corporation
ARNC
+$7.19M
2
AMED
Amedisys
AMED
+$6.82M
3
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$6.05M
4
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$5.57M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$3.73M

Top Sells

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$8.21M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$7.79M
3
TA
TravelCenters of America LLC
TA
+$7.69M
4
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$7.6M
5
VMW
VMware, Inc
VMW
+$7.25M

Sector Composition

Rank Sector Weight
1 Healthcare 14.58%
2 Industrials 6.24%
3 Consumer Staples 4.26%
4 Technology 1.62%
5 Communication Services 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AQUA
126
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
– –
-156,740
Closed -$7.79M
TA
127
DELISTED
TravelCenters of America LLC
TA
– –
-88,926
Closed -$7.69M
MAXR
128
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
– –
-77,821
Closed -$3.97M
OSH
129
DELISTED
Oak Street Health, Inc.
OSH
– –
-212,224
Closed -$8.21M
PRVB
130
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-315,391
Closed -$7.6M
2 3 4 5
6

Similar funds

MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
PA
PharVision Advisers Boca Raton, Florida $9.86M AUM 9.93% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Crabel Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Crabel Capital Management held 130 positions worth $242M, up 7.5% from $225M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Crabel Capital Management deployed $11.3M of net new capital in Q2 2023, opening 46 new positions and adding to 34 existing holdings. Its largest new stake was Arconic Corporation: 260,688 shares worth $7.71M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $3.13M trimmed.

  • Crabel Capital Management's largest Q2 2023 buy was Arconic Corporation: 260,688 shares worth $7.71M.
  • Crabel Capital Management added most to iShares Preferred and Income Securities ETF in Q2 2023, an estimated $3.51M increase.
  • Crabel Capital Management's biggest Q2 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.13M.
  • Crabel Capital Management fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $8.21M.
  • Crabel Capital Management's ten largest holdings make up 35% of its $242M portfolio in Q2 2023.
  • Crabel Capital Management opened 46 new positions and closed 20 in Q2 2023.
  • Crabel Capital Management's portfolio value rose 7.5% quarter-over-quarter to $242M.

Based on Crabel Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.